Sequent Scientific Stock Screener | Share Price & Fundamental Analysis
SEQUENT
Pharmaceuticals
Screen Sequent Scientific share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹206.94
▼
-3.55 (-1.69%)
Share Price BSE
₹206.80
▼
-3.85 (-1.83%)
Market Cap
₹5,341.45 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.76
EPS (TTM)
₹0.88
Dividend Yield
-
Debt to Equity
0.71
52W High
₹252.00
52W Low
₹126.68
Operating Margin
11.00%
Profit Margin
2.48%
Revenue (TTM)
₹403.00
EBITDA
₹48.00
Net Income
₹10.00
Total Assets
₹1,602.00
Total Equity
₹770.00
Sequent Scientific Share Price History - Stock Screener Chart
Screen SEQUENT historical share price movements with interactive charts. Analyze price trends and patterns.
Sequent Scientific Company Profile - Fundamental Screener
Screen Sequent Scientific company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SEQUENT shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE807F01027
Sequent Scientific Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SEQUENT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,602 | 1,540 | 1,529 | 1,451 | 1,393 | 1,463 | 1,388 | 1,343 | 1,905 | 1,528 |
| Current Assets | 873 | 811 | 780 | 783 | 714 | 704 | 600 | 538 | 728 | 491 |
| Fixed Assets | 586 | 592 | 605 | 564 | 536 | 577 | 498 | 476 | 684 | 587 |
| Liabilities | ||||||||||
| Total Liabilities | 1,602 | 1,540 | 1,529 | 1,451 | 1,393 | 1,463 | 1,388 | 1,343 | 1,905 | 1,528 |
| Current Liabilities | 327 | 200 | 221 | 199 | 156 | 236 | 207 | 227 | 247 | 290 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 770 | 713 | 749 | 740 | 776 | 732 | 747 | 685 | 994 | 948 |
| Share Capital | 50 | 50 | 50 | 50 | 50 | 50 | 49 | 49 | 49 | 48 |
| Reserves & Surplus | 654 | 607 | 649 | 633 | 678 | 637 | 657 | 599 | 928 | 885 |
Screen SEQUENT income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403 | 445 | 426 | 365 | 393 | 373 | 397 | 368 | 334 | 356 | 337 | 388 | 342 | 339 | 378 |
| Expenses | 356 | 391 | 370 | 334 | 348 | 334 | 357 | 432 | 365 | 331 | 307 | 350 | 342 | 335 | 365 |
| EBITDA | 48 | 55 | 56 | 32 | 45 | 39 | 40 | -63 | -31 | 25 | 30 | 37 | 0 | 4 | 13 |
| Operating Profit % | 11.00% | 12.00% | 13.00% | 8.00% | 11.00% | 9.00% | 9.00% | -18.00% | -10.00% | 4.00% | 7.00% | 9.00% | 0.00% | 1.00% | 3.00% |
| Depreciation | 16 | 15 | 16 | 17 | 16 | 17 | 17 | 15 | 14 | 15 | 16 | 13 | 14 | 13 | 14 |
| Interest | 15 | 14 | 14 | 12 | 16 | 14 | 15 | 11 | 11 | 13 | 13 | 6 | 7 | 8 | 10 |
| Profit Before Tax | 16 | 26 | 27 | 3 | 12 | 8 | 8 | -89 | -56 | -3 | 2 | 18 | -21 | -18 | -10 |
| Tax | 6 | 8 | 8 | 1 | 3 | 2 | 2 | 4 | -21 | 4 | -9 | 8 | -6 | -13 | 0 |
| Net Profit | 10 | 18 | 20 | 1 | 9 | 6 | 7 | -92 | -35 | -7 | 11 | 10 | -15 | -4 | -10 |
| EPS | 0.37 | 0.57 | 0.59 | -0.04 | 0.26 | 0.11 | 0.14 | -3.77 | -1.40 | -0.34 | 0.33 | 0.36 | -0.60 | -0.15 | -0.36 |
Sequent Scientific Cash Flow Screener - Liquidity Fundamentals
Screen SEQUENT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 83 | 31 | 17 | 31 | 115 | 115 | 116 | 45 | -7 | 0 |
| Investing Activities | -25 | -6 | -65 | -94 | 10 | -72 | -68 | 7 | -116 | -311 |
| Financing Activities | -61 | -1 | 32 | 67 | -139 | -43 | -20 | -57 | 147 | 309 |
| Net Cash Flow | -2 | 23 | -16 | 4 | -14 | 0 | 28 | -5 | 24 | -2 |
Screen SEQUENT shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.61% | 52.61% | 52.33% | 61.43% | 52.79% | 52.78% | 52.76% | 52.61% |
| FII Holding | 6.05% | 6.15% | 5.91% | 3.16% | 6.16% | 5.70% | 6.45% | 6.10% |
| DII Holding | 12.82% | 12.98% | 12.91% | 7.35% | 7.59% | 8.06% | 9.99% | 12.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.43% | 22.37% | 22.72% | 19.24% | 24.43% | 25.01% | 24.00% | 23.82% |
| Other Holding | 5.09% | 5.89% | 6.13% | 8.83% | 9.02% | 8.45% | 6.80% | 5.46% |
| Shareholder Count | 158,152 | 147,320 | 144,085 | 135,389 | 166,593 | 163,693 | 154,603 | 162,574 |
Sequent Scientific Dividend Screener - Share Yield Analysis
Screen SEQUENT dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.50 | 0.37% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.20 | 0.26% |
| 2018-March | ₹0.20 | 0.28% |
| 2017-March | ₹0.00 | 0.00% |
Sequent Scientific Index Membership - Market Screener Classification
Screen SEQUENT by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sequent Scientific Market Events Screener - Corporate Actions
Screen SEQUENT market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.50 /share | -26.73% | ||
| Annual General Meeting | NA | 7.61% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 6.35% |
| 2025-08-30 | 2025-08-30 | Extraordinary General Meeting | NA | -2.53% |
| 2025-08-26 | 2025-08-26 | Extraordinary General Meeting | NA | -0.29% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | -3.66% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.48% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 15.69% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -2.09% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.87% |
Sequent Scientific Competitors Screener - Peer Comparison
Screen SEQUENT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,653 | 39.37 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 169,794 | 67.76 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 131,439 | 60.85 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 122,135 | 22.30 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,729 | 18.24 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,193 | 22.10 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,292 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 90,854 | 50.34 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 70,620 | 20.25 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 66,932 | 27.11 | 13,458 | 3.70% | 2,216 | 38.49 |
Sequent Scientific Company Announcements - News Screener
Screen SEQUENT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-03 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-12-28 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-19 | Closure of Trading Window | View |
| 2025-12-17 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-17 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-16 | Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2025 (SEBI Listing Regulations) And Outcome Of Board Meeting Of The Company | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-28 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-26 | Intimation Of Record Date Under Regulation 42 Of SEBI | View |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |